Clinical trial
Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS
NCT03535298
Study timeline
Study start (actual)2019-01-03Date precision: day
Registry last updated2026-08-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosis, Relapsing-Remittingunresolved
Interventions
Sponsors & collaborators
The Cleveland Cliniclead sponsor
University of Nottinghamcollaborator
Mapped research locations
HoustonTexas, United States2ClevelandOhio, United States1CincinnatiOhio, United States1ColumbusOhio, United States1MinneapolisMinnesota, United States1AuroraColorado, United States1AustinTexas, United States1RochesterNew York, United States1Las VegasNevada, United States1RochesterMinnesota, United States1RichmondVirginia, United States1MadisonWisconsin, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03535298 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.